TMO Financial Facts
Income from Continuing Operations: 473.5MOther Expense, Net: -113.2M
See Full Income Statement
Total current liabilities: 5.26B
Property, Plant and Equipment at Cost, Net: 2.6B
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
| Next EPS Date | 7/22/21 *Est. | EPS Growth Rate | +145.2% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +22.2% | Revenue Growth Rate | +59.1% *Last Qtr. |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/29/21 |  |
Q121 | $7.21 | $6.65 | +$0.56 | $9.91B | $9.72B | N/A |  | | Details |
| 2/1/21 | |
Q420 | $7.09 | $6.29 | +$0.80 | $10.55B | $9.3B | N/A | | | Details |
| 10/21/20 | |
Q320 | $5.63 | $4.31 | +$1.32 | $8.52B | $7.65B | N/A | | | Details |
| 7/22/20 | |
Q220 | $3.89 | $2.84 | +$1.05 | $6.92B | $6.13B | N/A | | | Details |
| 4/22/20 | |
Q120 | $2.94 | $2.79 | +$0.15 | $6.23B | $6.17B | N/A | | | Details |
| 1/30/20 | |
Q419 | $3.55 | $3.54 | +$0.01 | $6.83B | $6.78B | N/A | | | Details |
| 10/23/19 | |
Q319 | $2.94 | $2.87 | +$0.07 | $6.27B | $6.18B | = | | | Details |
| 7/24/19 | |
Q219 | $3.04 | $3.00 | +$0.04 | $6.32B | $6.3B | = | | | Details |
